Lancet commission : Seeks to eliminate TB by 2045
Tuberculosis was declared a global emergency by WHO 1993, Medical Journal Lancet had undertaken a study on Tuberculosis (TB) in three high-burden countries, including India Lancet seek to eliminate this disease by2045 The findings of the burden of TB in India are
In the report card of world TB ,India accounted for 27% of the 10 million people, who had developed TB in 2017. Also, India accounted for 32% of global TB deaths among HIV-negative people, and 27% of combined TB deaths in 2017. The high out-of-pocket expenses incurred during TB treatment keeps people in poverty for seven years after completing treatment as stated by the Union Health Minister.
The majority of MDR-TB cases in India due to direct transmission. Early diagnosis and prompt initiation of effective treatment should be a high priority for India to curb MDR-TB transmission since only 14% of people with MDR-TB completed treatment and just 11% remained disease-free at the end of one year.
India’s goal to end the epidemic by 2025 was too “ambitious” and “unrealistic”, Hence unattainable.57% reduction in incidence and 72% reduction in mortality will been seen only by 2035 and strengthening the care cascade could reduce cumulative TB incidence by 38% in the case of India
India needs to adopt measures to prevent TB commensurate with the population levels to eliminate the disease in the coming decades, India needs to improve diagnosis and treatment for drug-sensitive and drug-resistant TB.
Lives of eight million (28%) people with TB can be saved over the next 30 years if tests are subsidised and patients are supported to complete the treatment
For this subsidised and complete care, India requires an extra $290 million each year. This is significantly less than $32 billion losses which India incurs associated with TB mortality each year.
India needs to scale up access to TB services for all those seeking them, optimise engagement of private sector providers and guarantee universal access to drug susceptibility testing and second-line TB drugs.
Integration of TB services with the primary health system to reduce diagnostic delays is not happening.
Within a few decades, the Lancet medical journal’s Commission on Tuberculosis (TB) believes that the disease could be eliminated if proper funding, increased research, and greater accountability mechanisms are provided.